Experiments for taxon Leptadenia hastata (ASCLEPIADACEAE)

Experiments (111 results)

111 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
185621	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	KIDJOLANIN
390580	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	AMYRIN,BETA:TARAXASTEROLLUPEOL ACETATELUPEOL PALMITATEAMYRIN,ALPHA:CYCLOARTENOL,24-METHYLENE:TARAXASTEROL,PSEUDO:CYCLOARTENOLAMYRIN,GAMMA:
193923	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1193624	VOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)
185610	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL:
662936	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
493056	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
1243751	EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTITRYPANOSOMAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
185615	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN,12-O-NICOTINOYL-DEACETYL:
662941	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193939	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	CYANFORIDIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953988	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
922701	MEDICINAL FOLKLORE REPORTED FOR	WOUND HEALING ACCELERATION	Leptadenia hastata (ASCLEPIADACEAE)
953995	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193928	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL,3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193956	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN-3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953985	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
662935	VOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)
185608	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL:
185619	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN
193934	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	CYANFORIDIN-3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-CYMANOPYRANOSIDE
193945	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193922	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE
493055	VOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)
906568	MEDICINAL FOLKLORE REPORTED FOR	GENITOURINARY EFFECT(UNSPECIFIED)	Leptadenia hastata (ASCLEPIADACEAE)
193951	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
185622	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN
185614	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL:
906566	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIACNE ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193918	PMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-BENZOYL-12-O-CINNAMOYL:
1193627	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIFUNGAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
185611	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-ACETYL-12-O-CINNAMOYL:
922700	MEDICINAL FOLKLORE REPORTED FOR	WOUND HEALING ACCELERATION	Leptadenia hastata (ASCLEPIADACEAE)
953982	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193929	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN-3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662939	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
906567	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
185618	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953986	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)	O
922699	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953994	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193930	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	CYNANFORDIN-3-O-BETA-D-OLEANDROPYRANOSYL(14)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMPAROPYRANOSIDE
193941	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	KIDJOLANIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953990	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193952	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE CYTOTOXICITY(G1 PHASE)	Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662942	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193955	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE CYTOTOXICITY(G1 PHASE)	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193954	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193933	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-CINNAMOYL-20-O-NICOTINOYL,3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193925	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-20-DI-O-BENZOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193944	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
906569	MEDICINAL FOLKLORE REPORTED FOR	EYE PROBLEMS(UNSPECIFIED)	Leptadenia hastata (ASCLEPIADACEAE)
193943	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662938	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193919	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	GAGAMININ,ISO:
185612	ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR	ANTITUMOR ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193959	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE CYTOTOXICITY(G1 PHASE)	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193958	PHARMACOLOGY OF COMPOUND - IN VITRO	DNA SYNTHESIS INHIBITION	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953983	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
185624	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CYTOTOXIC ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENINKIDJOLANINSARCOSTIN,12-20-O-DIBENZOYL:METAPLEXIGENINMETAPLEXIGENIN,12-O-NICOTINOYL-DEACETYL:SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL:SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 30-O-BETA-D-CYMAROPYRANOSIDECYNANFORIDINPENUPOGENIN 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDESARCOSTIN,20-O-ACETYL-12-O-CINNAMOYL:SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDESARCOSTIN,12-O-ACETYL:GAGAMININSARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL:
922698	VOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)
193937	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL,3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
185623	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	CYNANFORIDIN
906564	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193948	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-BENZOYL-12-O-CINNAOMOYL: 3-O-BETA-D-GLUCOPYRNOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1193626	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953987	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
493058	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953993	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
185613	MEDICINAL FOLKLORE REPORTED FOR	ANTIINFLAMMATORY ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193936	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-CINNAMOYL-20-META-HYDROXY-BENZOYL: 3-O-BETA-D-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRNAOSIDE
193921	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
185617	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN 3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
953979	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953991	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193926	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,20-O-ACETYL-12-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662943	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953980	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193940	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANSOYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193947	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL,3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193942	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,17-O-ACETYL-20-O-CINNAMOYL-12-O-NICOTINOYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193953	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662937	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193931	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-OLEANDROPYRANSOYL(1-4)-BETA-D-CYMAROPYRNAOSIDE
185620	QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Leptadenia hastata (ASCLEPIADACEAE)	GAGAMININ
185616	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 30-O-BETA-D-CYMAROPYRANOSIDE
193924	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1193625	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953978	PHYTOCHEMICAL SCREENING FORVOUCHER SPECIMEN REPORTED FOR		Leptadenia hastata (ASCLEPIADACEAE)	O
953989	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193938	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193957	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
1243750	EFFECTS DUE TO A COMBINATION OF DRUGSANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTITRYPANOSOMAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
906565	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193949	QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	KIDJOLANIN-3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
643097	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIOXIDANT ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
922702	ANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)MEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953984	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193927	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662940	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
493057	PHARMACOLOGY OF EXTRACT - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ANTICRUSTACEAN ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953992	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193950	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662944	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
953981	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193946	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL CYCLE CYTOTOXICITY(G1 PHASE)	Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
662945	PHARMACOLOGY OF EXTRACT - IN VITRO	ANTIBACTERIAL ACTIVITY	Leptadenia hastata (ASCLEPIADACEAE)
193920	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-20-DI-O-ACETYL:
193935	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	METAPLEXIGENIN,12-O-NICOTINOYL-DEACETYL,3-O-BETA-D-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
193932	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-20-O-DIBENZOYL: 3-O-BETA-6-DEXOY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
185609	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE		Leptadenia hastata (ASCLEPIADACEAE)	SARCOSTIN,12-20-O-DIBENZOYL:

Experiments for taxon Leptadenia hastata (ASCLEPIADACEAE)

Experiments (111 results)

Filters

Worktypes (14)

Pharmacology (15)

Compounds (59)

Organisms (14)